H.R. 171 · 118th Congress (2023–2025)
HALT Fentanyl Act
This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Show official title
To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 171’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. H. Morgan Griffith (R-VA-9)
- Cosponsors
2 cosponsors
1 original · 1 later
- Rep. Robert E. Latta (R-OH-5)· Original · Jan 9, 2023
- Rep. Brad Finstad (R-MN-1)· Later · Feb 1, 2023
- Policy area
- Crime and Law Enforcement
- Subjects
- Administrative law and regulatory procedures
- Department of Justice
- Drug trafficking and controlled substances
- Licensing and registrations
- Research administration and funding
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jan 9, 2023 – Jan 20, 2023
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
HALT Fentanyl Act
Display title, Short title · Introduced in House
Halt All Lethal Trafficking of Fentanyl Act
Short title · Introduced in House
To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Official title · Introduced in House